Nov
Agarwal D, Zafar I, Ahmad SU, Kumar S, Ain QU, Sundaray JK, Rather MA. Structural, genomic information and computational analysis of emerging coronavirus (SARS-CoV-2). Bull Natl Res Centre. 2022;46(1):170. Article Google Scholar Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023:1–14. Sauve F, Nampoothiri S, […]
Nov
The FDA on Wednesday granted marketing authorization to the first chlamydia and gonorrhea test that allows for at-home sample collection. Intended for adults, the over-the-counter (OTC) Simple 2 test marks the first home diagnostic for sexually transmitted infections (STIs) outside of those for HIV. “This authorization marks an important public health milestone, giving patients more […]
Nov
November 16, 2023 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . <button type="button" class="btn btn-primary" data-loading-text="Loading ” data-action=”subscribe”> Subscribe Added to email alerts We were unable to process your request. […]
Cardiovascular
Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis
Nov
Abstract Objective To assess the absolute treatment effects of intravascular imaging guided versus angiography guided percutaneous coronary intervention in patients with coronary artery disease, considering their baseline risk. Design Systematic review and meta-analysis. Data sources PubMed/Medline, Embase, and Cochrane Library databases up to 31 August 2023. Study selection Randomized controlled trials comparing intravascular imaging (intravascular […]
Nov
Germany’s Federal Ministry of Education and Research is funding the establishment of the Leibniz Centre for Photonics in Infection Research (LPI) at the Jena University Hospital. The center aims to advance the development of light-based medical technology, and it is intended to expedite the translation of research results into marketable products in a standardized process […]
Nov
Takeda’s Adzynma (ADAMTS13, recombinant-krhn) for the treatment of congenital thrombotic thrombocytopenic purpura (cTTP) was given the green light on November 9. This is good news for any affected by the life-threatening disorder that needs prompt diagnosis, early referral, and effective, immediate management. Takeda has been working with the rare hematology community for more than 70 years […]
